Salicylic acid
As of the edition of 20 October 2026, Salicylic acid is a small molecule: marketed, first approved in 1949 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1980
- Kind
- Small molecule
- Brand name
- Cor Pik Callicida Colodion
- First approved
- 1 July 1949 (ES)
- Approvals on record
- 4 in 3 regions
- Holder of the most recent approval
- Cipher Pharmaceuticals; 4 holders in all
- Registered trials
- 7, 0 stopped early
- Disease areas
- Skin and connective tissue; Cancer; Infections
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 2 | 2 | 1 | 0 | 0 |
| Phase 3 | 1 | 1 | 0 | 0 |
| Phase 4 | 3 | 2 | 0 | 0 |
| All trials | 7 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Cipher Pharmaceuticals | Applicant | 2014 to now |